top of page
This activity is jointly provided by Medical Education Resources and Focus Medical Communications.
Supported by educational grants from Gilead Sciences, Inc. and Salix Pharmaceuticals.
This activity has been designed to meet the educational needs of health care professionals involved in the care of patients with chronic liver disease (CLD) and gastrointestinal (GI) disorders.
After completing this activity, the participant should be better able to:
Describe current screening, diagnosis, and management options for patients with chronic liver disease (CLD) and gastrointestinal (GI) disorders
Apply optimal treatment strategies for patients with CLD and GI disorders
Compare and contrast currently available treatment modalities for CLD and GI disorders
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and CLDF. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Medical Education Resources designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits™.
Disclosure of Conflicts of Interest
It is the policy of Medical Education Resources to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are mitigated by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.
bottom of page